Everything old is new again: the case for imatinib as frontline therapy in 2017.
Everything old is new again: the case for imatinib as frontline therapy in 2017.
Clin Adv Hematol Oncol. 2017 Apr;15(4):302-305
Authors: Lee SG, Lipton JH
PMID: 28591105 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research